These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. (-)-Reboxetine inhibits muscle nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites. Arias HR; Ortells MO; Feuerbach D Neurochem Int; 2013 Nov; 63(5):423-31. PubMed ID: 23917086 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory mechanisms and binding site location for serotonin selective reuptake inhibitors on nicotinic acetylcholine receptors. Arias HR; Feuerbach D; Bhumireddy P; Ortells MO Int J Biochem Cell Biol; 2010 May; 42(5):712-24. PubMed ID: 20079457 [TBL] [Abstract][Full Text] [Related]
7. Interaction of bupropion with muscle-type nicotinic acetylcholine receptors in different conformational states. Arias HR; Gumilar F; Rosenberg A; Targowska-Duda KM; Feuerbach D; Jozwiak K; Moaddel R; Wainer IW; Bouzat C Biochemistry; 2009 Jun; 48(21):4506-18. PubMed ID: 19334677 [TBL] [Abstract][Full Text] [Related]
8. Selectivity of coronaridine congeners at nicotinic acetylcholine receptors and inhibitory activity on mouse medial habenula. Arias HR; Jin X; Feuerbach D; Drenan RM Int J Biochem Cell Biol; 2017 Nov; 92():202-209. PubMed ID: 29042244 [TBL] [Abstract][Full Text] [Related]
9. 5-Doxylstearate-induced displacement of phencyclidine from its low-affinity binding sites on the nicotinic acetylcholine receptor. Arias HR Arch Biochem Biophys; 1999 Nov; 371(1):89-97. PubMed ID: 10525293 [TBL] [Abstract][Full Text] [Related]
10. Coronaridine congeners inhibit human α3β4 nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites. Arias HR; Targowska-Duda KM; Feuerbach D; Jozwiak K Int J Biochem Cell Biol; 2015 Aug; 65():81-90. PubMed ID: 26022277 [TBL] [Abstract][Full Text] [Related]
11. Determinants of phencyclidine potency on the nicotinic acetylcholine receptors from muscle and electric organ. Eterović VA; Lu R; Eakin AE; Rodríguez AD; Ferchmin PA Cell Mol Neurobiol; 1999 Dec; 19(6):745-57. PubMed ID: 10456235 [TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms and binding site location for the noncompetitive antagonist crystal violet on nicotinic acetylcholine receptors. Arias HR; Bhumireddy P; Spitzmaul G; Trudell JR; Bouzat C Biochemistry; 2006 Feb; 45(7):2014-26. PubMed ID: 16475790 [TBL] [Abstract][Full Text] [Related]
13. Structural and functional interaction of (±)-2-(N-tert-butylamino)-3'-iodo-4'-azidopropiophenone, a photoreactive bupropion derivative, with nicotinic acetylcholine receptors. Arias HR; Feuerbach D; Targowska-Duda KM; Aggarwal S; Lapinsky DJ; Jozwiak K Neurochem Int; 2012 Dec; 61(8):1433-41. PubMed ID: 23103524 [TBL] [Abstract][Full Text] [Related]
14. Different interaction between tricyclic antidepressants and mecamylamine with the human alpha3beta4 nicotinic acetylcholine receptor ion channel. Arias HR; Targowska-Duda KM; Feuerbach D; Sullivan CJ; Maciejewski R; Jozwiak K Neurochem Int; 2010 Mar; 56(4):642-9. PubMed ID: 20117161 [TBL] [Abstract][Full Text] [Related]
15. Interaction of d-tubocurarine analogs with the mouse nicotinic acetylcholine receptor. Ligand orientation at the binding site. Papineni RV; Pedersen SE J Biol Chem; 1997 Oct; 272(40):24891-8. PubMed ID: 9312090 [TBL] [Abstract][Full Text] [Related]
16. The muscarinic antagonists aprophen and benactyzine are noncompetitive inhibitors of the nicotinic acetylcholine receptor. Amitai G; Herz JM; Bruckstein R; Luz-Chapman S Mol Pharmacol; 1987 Nov; 32(5):678-85. PubMed ID: 3683366 [TBL] [Abstract][Full Text] [Related]